LifeMine Stock
HealthTechLooking to sell LifeMine stock or options?
LifeMine is the developer of a drug discovery platform designed to unravel human biology and craft advanced therapeutics targeting the core drivers of serious human diseases. Leveraging fungal biodiversity, the company's platform develops therapeutics that are both mechanistically and structurally novel, addressing previously insurmountable therapeutic challenges. By doing so, LifeMine enables healthcare providers to tackle difficult human diseases through innovative biological mechanisms.
6 Dimensions Capital, Fidelity Management & Research, Merck & Co., Foresite Capital, Milky Way Investments Group, Richard Klausner, Blue Pool Capital, GV, 3W Partners Capital, The Invus Group, Alexandria Venture Investments, MRL Ventures Fund, GSK, WuXi Healthcare Investment Consulting, ARCH Venture Partners, Boyu Capital.